Skip to main content
. 2017 Jan 23;12(1):e0170352. doi: 10.1371/journal.pone.0170352

Fig 4. 526A inhibits IAV-induced IRF3 and STAT1 activation.

Fig 4

The A549-PB1 cells were treated with various concentrations of 526A as indicated for four hours followed by PR8-PB1flank-eGFP IAV infection at an MOI of 1.0 for twelve hours. Whole cell extracts were prepared and immunoblotted with antibodies against PARP, p-IRF3 and p-STAT1.